Catalog.No.	maxControlTPMiCard	maxControlTPMfibro	meanControlTPMiCard	meanControlTPMfibro	Product.Name	Class	M.w.	CAS.Number	Form	Targets	Information	Smiles	Max.Solubility.in.DMSO..mM.	URL	Pathway	alreadyPurchased	GeneSymbolList	medianIC50S1107	24.44000123	54.06725073	5.904591211	17.75330831	Danusertib (PHA-739358)	kinase	474.55	827318-97-8	free base	"c-RET,FGFR,Bcr-Abl,Aurora Kinase"	"Danusertib (PHA-739358) is an Aurora kinase inhibitor for Aurora A/B/C with IC50 of 13 nM/79 nM/61 nM, modestly potent to Abl, TrkA, c-RET and FGFR1, and less potent to Lck, VEGFR2/3, c-Kit, CDK2, etc. Phase 2."	C1(=CC=CC=C1)[C@H](C(N2CC3=C(C2)C(=NN3)NC(=O)C4=CC=C(C=C4)N5CCN(CC5)C)=O)OC	200	http://www.selleckchem.com/products/PHA-739358(Danusertib).html	Cell Cycle	FALSE	AURKA^AURKB^AURKC^ABL1^NTRK1^RET^FGFR1	61S1124	18.70185933	84.95204102	5.531944617	18.09323169	BMS-754807	kinase	461.49	1001350-96-4	free base	"IGF-1R,Trk receptor,c-Met"	"BMS-754807 is a potent and reversible inhibitor of IGF-1R/InsR with IC50 of 1.8 nM/1.7 nM, less potent to Met, Aurora A/B, TrkA/B and Ron, and shows little activity to Flt3, Lck, MK2, PKA, PKC etc. Phase 1/2."	C12N(N=C(N=C1NC3C=C(NN=3)C4CC4)N5CCC[C@]5(C)C(=O)NC6=CC=C(N=C6)F)C=CC=2	199	http://www.selleckchem.com/products/BMS-754807.html	Protein Tyrosine Kinase	FALSE	IGF1R^INSR^MET^AURKA^AURKB^NTRK1^NTRK2^MST1R	7.4S1134	24.44000123	54.06725073	10.14017045	20.47873885	AT9283	kinase	381.43	896466-04-9	free base	"JAK,Aurora Kinase,Bcr-Abl"	"AT9283 is a potent JAK2/3 inhibitor with IC50 of 1.2 nM/1.1 nM; also potent to Aurora A/B, Abl(T315I). Phase 1/2."	N(C(=O)NC1C(=NNC=1)C2NC3C(N=2)=CC(=CC=3)CN4CCOCC4)C5CC5	199	http://www.selleckchem.com/products/AT9283.html	JAK/STAT	FALSE	JAK2^JAK3^AURKA^AURKB^ABL1	10S1178	23.23611563	87.47917126	5.511550443	23.15883573	Regorafenib (BAY 73-4506)	kinase	482.82	755037-03-7	free base	"c-RET,VEGFR"	"Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRë_, Kit, RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM, respectively."	C1=NC(=CC(=C1)OC2=CC(=C(C=C2)NC(NC3=CC=C(C(=C3)C(F)(F)F)Cl)=O)F)C(=O)NC	200	http://www.selleckchem.com/products/BAY-73-4506.html	Protein Tyrosine Kinase	FALSE	FLT1^KDR^PDGFRA^KIT^RET^RAF1	10S1194	43.68740397	25.36173877	10.02126479	11.16819602	CUDC-101	kinase	434.49	1012054-59-9	free base	"HDAC,HER2,EGFR"	"CUDC-101 is a potent multi-targeted inhibitor against HDAC, EGFR and HER2 with IC50 of 4.4 nM, 2.4 nM, and 15.7 nM, and inhibits class I/II HDACs, but not class III, Sir-type HDACs. Phase 1."	C12=C(N=CN=C1NC3=CC(=CC=C3)C#C)C=C(C(=C2)OCCCCCCC(NO)=O)OC	46	http://www.selleckchem.com/products/CUDC-101.html	Epigenetics	FALSE	EGFR^ERBB2^HDAC1^HDAC2^HDAC3^HDAC8^HDAC4^HDAC5^HDAC7^HDAC9^HDAC6^HDAC10	13S1275	24.91496787	28.14742491	18.44187507	17.03428084	BX-912	kinase	471.35	702674-56-4	free base	PDK-1	"BX912 is a potent and specific PDK1 inhibitor with IC50 of 12 nM, 9- and 105- fold greater selectivity for PDK1 than PKA and PKC, respectively. In comparison to GSK3ë_, selectivity for PDK1 is 600-fold."	N1(CCCC1)C(=O)NC2C=C(C=CC=2)NC3N=C(C(=CN=3)Br)NCCC4=CN=CN4	199	http://www.selleckchem.com/products/bx-912.html	PI3K/Akt/mTOR	FALSE	PDK1^PRKACA^PRKACB	200S1486	43.68740397	54.06725073	14.05795153	16.25963648	AEE788 (NVP-AEE788)	kinase	440.58	497839-62-0	free base	"HER2,VEGFR,EGFR"	"AEE788 is a potent inhibitor of EGFR and HER2/ErbB2 with IC50 of 2 nM and 6 nM, less potent to VEGFR2/KDR, c-Abl, c-Src, and Flt-1, does not inhibit Ins-R, IGF-1R, PKCë± and CDK1. Phase 1/2."	C1=NC(=C2C(=N1)NC(=C2)C3=CC=C(C=C3)CN4CCN(CC4)CC)N[C@@H](C5=CC=CC=C5)C	199	http://www.selleckchem.com/products/AEE788.html	Protein Tyrosine Kinase	FALSE	EGFR^ERBB2^KDR^ABL1^SRC^FLT1	52S2013	28.18665405	38.96516471	7.884511006	13.21724164	PF-573228	kinase	491.49	869288-64-2	free base	FAK	"PF-573228 is an ATP-competitive inhibitor of FAK with IC50 of 4 nM, ~50- to 250-fold selective for FAK than Pyk2, CDK1/7 and GSK-3ë_."	N1C(CCC2C=C(C=CC1=2)NC3N=C(C(=CN=3)C(F)(F)F)NCC4C=C(C=CC=4)S(=O)(=O)C)=O	52	http://www.selleckchem.com/products/pf-573228.html	Angiogenesis	FALSE	PTK2^CDK1^CDK7^GSK3A^GSK3B^PTK2B	4S2179	34.64576015	96.67601823	18.13869784	36.72409704	LY2784544	kinase	469.94	1229236-86-5	free base	JAK	"LY2784544 is a potent JAK2 inhibitor with IC50 of 3 nM, effective in JAK2V617F, 8- and 20-fold selective versus JAK1 and JAK3. Phase 2."	C1C(=NN2C(C=1CN3CCOCC3)=NC(=C2CC4=CC=C(C=C4F)Cl)C)NC5NN=C(C=5)C	200	http://www.selleckchem.com/products/LY2784544.html	JAK/STAT	FALSE	JAK1^JAK2^JAK3	48S2243	71.14912292	73.29547146	22.88713883	32.64554769	Degrasyn (WP1130)	kinase	384.27	856243-80-6	free base	"DUB,Bcr-Abl"	"WP1130 (Degrasyn) is a selective deubiquitinase (DUB: USP5, UCH-L1, USP9x, USP14, and UCH37) inhibitor and also suppresses Bcr/Abl, also a JAK2 transducer (without affecting 20S proteasome) and activator of transcription (STAT)."	C1(=CC=CC(=N1)/C=C(/C(N[C@H](C2=CC=CC=C2)CCC)=O)C#N)Br	200	http://www.selleckchem.com/products/WP1130.html	Angiogenesis	FALSE	USP5^UCHL1^USP9X^USP14^UCHL5^BCR^ABL1^JAK2	1000S2449	24.9268763	26.24815723	5.906192493	6.533101559	Forskolin	GPCR	410.5	66575-29-9	free base	cAMP	"Forskolin is a ubiquitous activator of eukaryotic adenylyl cyclase (AC), commonly used to raise levels of cAMP in the study and research of cell physiology."	C1CC([C@]2([C@]([C@@H]1O)([C@]3([C@@]([C@H]([C@H]2O)OC(C)=O)(O[C@](CC3=O)(C=C)C)C)O)C)[H])(C)C	199	http://www.selleckchem.com/products/forskolin.html	GPCR & G Protein	FALSE	ADCY1^ADCY2^ADCY3^ADCY4^ADCY5^ADCY6^ADCY7^ADCY8^ADCY9^ADCY10	500S2622	28.1340087	107.3980546	10.54932227	45.78460722	PP121	kinase	319.36	1092788-83-4	free base	"DNA-PK,PDGFR,mTOR"	"PP-121 is a multi-targeted inhibitor of PDGFR, Hck, mTOR, VEGFR2, Src and Abl with IC50 of 2 nM, 8 nM, 10 nM, 12 nM, 14 nM and 18 nM, also inhibits DNA-PK with IC50 of 60 nM."	C1(=CN=C2C(=C1)C=CN2)C3=NN(C4=C3C(=NC=N4)N)C5CCCC5	200	http://www.selleckchem.com/products/PP121.html	Protein Tyrosine Kinase	FALSE	PDGFRA^PDGFRB^HCK^KDR^SRC^ABL1^MTOR^PRKDC	11S2634	24.44000123	54.06725073	5.804393892	9.760002106	DCC-2036 (Rebastinib)	kinase	553.59	1020172-07-9	free base	Bcr-Abl	"DCC-2036 is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1/2."	C1(=C(C=C(C=C1)OC2=CC(=NC=C2)C(NC)=O)F)NC(NC3N(N=C(C=3)C(C)(C)C)C4=CC5=C(C=C4)N=CC=C5)=O	200	http://www.selleckchem.com/products/dcc-2036.html	Angiogenesis	FALSE	ABL1^SRC^LYN^FGR^HCK^KDR^FLT3^TEK	3S2658	14.09245053	17.25024523	6.999444491	9.288850537	GSK2126458 (GSK458)	kinase	505.5	1086062-66-9	free base	"PI3K,mTOR"	"GSK2126458 is a highly selective and potent inhibitor of p110ë±/ë_/ë«/ë_, mTORC1/2 with Ki of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM, respectively. Phase 1."	C1(C(=CC(=CC=1)F)F)S(=O)(=O)NC2C(=NC=C(C=2)C3C=C4C(=CC=NC(=CC=3)4)C5C=NN=CC=5)OC	197	http://www.selleckchem.com/products/gsk2126458.html	PI3K/Akt/mTOR	FALSE	MTOR^RPTOR^RICTOR^MLST8^MAPKAP1	6S2692	19.52165291	11.6923621	4.946945575	3.378390757	TG101209	kinase	509.67	936091-14-4	free base	"JAK,FLT3,c-RET"	"TG101209 is a selective JAK2 inhibitor with IC50 of 6 nM, less potent to Flt3 and RET with IC50 of 25 nM and 17 nM, ~30-fold selective for JAK2 than JAK3, sensitive to JAK2V617F and MPLW515L/K mutations."	C1=C(C=C(C=C1)NC2=NC(=NC=C2C)NC3=CC=C(C=C3)N4CCN(CC4)C)S(NC(C)(C)C)(=O)=O	200	http://www.selleckchem.com/products/tg101209.html	JAK/STAT	FALSE	JAK2^JAK3^FLT3^RET	21S2791	12.10251731	51.06930823	2.794361655	8.615603494	Sotrastaurin	kinase	438.48	425637-18-9	free base	PKC	"Sotrastaurin is a potent and selective pan-PKC inhibitor, mostly for PKCëü with Ki of 0.22 nM; inactive to PKCë¦. Phase 1/2."	N1C(C(=C(C1=O)C2N=C(N=C3C=CC=CC=23)N4CCN(CC4)C)C5=CNC6C=CC=CC5=6)=O	198	http://www.selleckchem.com/products/sotrastaurin-aeb071.html	TGF-beta/Smad	FALSE	PRKCA^PRKCB^PRKCG^PRKCE^PRKCD^PRKCZ^PRKCH^PRKCI^PRKCQ	1.5S2801	638.093109	34.91197923	85.34954181	9.408361346	AZD4547	kinase	463.57	1035270-39-3	free base	FGFR	"AZD4547 is a novel selective FGFR inhibitor targeting FGFR1/2/3 with IC50 of 0.2 nM/2.5 nM/1.8 nM, weaker activity against FGFR4, VEGFR2(KDR), and little activity observed against IGFR, CDK2, and p38. Phase 1/2."	C1(=CC(=CC(=C1)CCC2=CC(=NN2)NC(=O)C3=CC=C(C=C3)N4C[C@@H](N[C@@H](C4)C)C)OC)OC	198	http://www.selleckchem.com/products/azd4547.html	Angiogenesis	FALSE	FGFR1^FGFR2^FGFR3^FGFR4^KDR^IGF2^CDK2^MAPK14	2S2820	18.70185933	84.95204102	8.108777495	21.59649991	TAE226 (NVP-TAE226)	kinase	468.94	761437-28-9	free base	FAK	"NVP-TAE226 is a potent FAK inhibitor with IC50 of 5.5 nM and modestly potent to Pyk2, ~10- to 100-fold less potent against InsR, IGF-1R, ALK, and c-Met."	C1(=CC(=C(C=C1)NC2=NC(=C(C=N2)Cl)NC3=C(C=CC=C3)C(NC)=O)OC)N4CCOCC4	200	http://www.selleckchem.com/products/nvp-tae226.html	Angiogenesis	FALSE	PTK2^PTK2B^ALK^INSR^MET^IGF1R	50S2867	27.98827474	54.06725073	10.22141819	20.07493322	WHI-P154	kinase	376.2	211555-04-3	free base	"JAK,EGFR"	"WHI-P154 is a potent JAK3 inhibitor with IC50 of 1.8 ë_M, no activity against JAK1 or JAK2, also inhibits EGFR, Src, Abl, VEGFR and MAPK, prevents Stat3, but not Stat5 phosphorylation."	N1C=NC(=C2C=C(C(=CC=12)OC)OC)NC3C=C(C(=CC=3)O)Br	199	http://www.selleckchem.com/products/whi-p154.html	JAK/STAT	FALSE	JAK3^EGFR^SRC^ABL1^FLT1^MAPK1	50S2891	23.23611563	28.13759023	9.131250434	11.15869116	GW441756	kinase	275.3	504433-23-2	free base	Trk receptor	"GW441756 is a potent, selective inhibitor of TrkA with IC50 of 2 nM, with very little activity to c-Raf1 and CDK2."	C1=CC=C2C(=N1)C(C(N2)=O)=CC3=CN(C4=C3C=CC=C4)C	90	http://www.selleckchem.com/products/gw-441756.html	Protein Tyrosine Kinase	FALSE	NTRK1^RAF1^CDK2	2S2913	10.89395452	18.59289803	6.293279239	10.36091363	BAY 11-7082	kinase	207.25	19542-67-7	free base	"Ië¼B/IKK,E2 conjugating"	"BAY 11-7082 is a NF-ë¼B inhibitor, inhibits TNFë±-induced Ië¼Bë± phosphorylation with IC50 of 10 ë_M."	C1(S(/C=C/C#N)(=O)=O)C=CC(=CC=1)C	197	http://www.selleckchem.com/products/bay-11-7082-bay-11-7821.html	NF-ë¼B	FALSE	NFKB1^NFKB2^RELA^RELB^REL	5000S7050	14.09245053	17.25024523	8.90306966	14.24421996	AZ20	kinase	412.51	1233339-22-4	free base	ATM/ATR	"AZ20 is a novel potent and selective inhibitor of ATR kinase with IC50 of 5 nM, 8-fold selectivity over mTOR."	C1=C(N=C(N=C1N2[C@@H](COCC2)C)C3=CC=CC4=C3C=CN4)C5(S(C)(=O)=O)CC5	201	http://www.selleckchem.com/products/az20.html	PI3K/Akt/mTOR	FALSE	MTOR^ATR	5S7195	21.135686	77.47978744	20.83457076	71.29477842	RKI-1447	kinase	326.37	1342278-01-6	free base	ROCK	"RKI-1447 is a potent inhibitor of ROCK1 and ROCK2, with IC50 of 14.5 nM and 6.2 nM, respectively, has anti-invasive and antitumor activities."	C1=NC=CC(=C1)C2N=C(SC=2)NC(NCC3=CC=CC(=C3)O)=O	199	http://www.selleckchem.com/products/rki-1447.html	Cell Cycle	FALSE	ROCK1^ROCK2	10S7338	25.17983383	20.70785042	18.39419305	17.19039977	AZ191	kinase	429.52	N/A	free base	Others	"AZ191 is a potent and selective DYRK1B inhibitor with IC50 of 17 nM, about 5- and 110-fold selectivity over DYRK1A and DYRK2, respectively."	C1=NC=C2C(=C1)C(=CN2C)C3=NC(=NC=C3)NC4=CC=C(C=C4OC)N5CCN(CC5)C	200	http://www.selleckchem.com/products/az191.html	Others	FALSE	DYRK1B^DYRK1A^DYRK2	50S8015	24.44000123	87.47917126	8.792644819	28.6335399	CEP-32496	kinase	517.46	1188910-76-0	free base	"CSF-1R,Raf"	"CEP-32496 is a highly potent inhibitor of BRAF(V600E/WT) and c-Raf with Kd of 14 nM/36 nM and 39 nM, also potent to Abl-1, c-Kit, Ret, PDGFRë_ and VEGFR2, respectively; insignificant affinity for MEK-1, MEK-2, ERK-1 and ERK-2. Phase 1/2."	N(C(=O)NC1=NOC(=C1)C(C(F)(F)F)(C)C)C2C=C(C=CC=2)OC3N=CN=C4C=C(C(=CC=34)OC)OC	17	http://www.selleckchem.com/products/cep-32496.html	MAPK	FALSE	BRAF^RAF1^ABL1^KIT^RET^PDGFRA^KDR	2